[PDF][PDF] Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments

RS Duman, G Sanacora, JH Krystal - Neuron, 2019 - cell.com
The mechanisms underlying the pathophysiology and treatment of depression and stress-
related disorders remain unclear, but studies in depressed patients and rodent models are …

Prefrontal cortex circuits in depression and anxiety: contribution of discrete neuronal populations and target regions

BD Hare, RS Duman - Molecular psychiatry, 2020 - nature.com
Our understanding of depression and its treatment has advanced with the advent of
ketamine as a rapid-acting antidepressant and the development and refinement of tools …

[HTML][HTML] Sex differences in stress-related alcohol use

MKR Peltier, TL Verplaetse, YS Mineur, IL Petrakis… - Neurobiology of …, 2019 - Elsevier
Rates of alcohol use disorder (AUD) have increased in women by 84% over the past ten
years relative to a 35% increase in men. This substantive increase in female drinking is …

[HTML][HTML] Probiotics, prebiotics and postbiotics on mitigation of depression symptoms: Modulation of the brain–gut–microbiome axis

A Chudzik, A Orzyłowska, R Rola, GJ Stanisz - Biomolecules, 2021 - mdpi.com
The brain–gut–microbiome axis is a bidirectional communication pathway between the gut
microbiota and the central nervous system. The growing interest in the gut microbiota and …

[HTML][HTML] Cortical GABAergic dysfunction in stress and depression: new insights for therapeutic interventions

MV Fogaça, RS Duman - Frontiers in cellular neuroscience, 2019 - frontiersin.org
Major depressive disorder (MDD) is a debilitating illness characterized by neuroanatomical
and functional alterations in limbic structures, notably the prefrontal cortex (PFC), that can be …

Altered GABA-mediated information processing and cognitive dysfunctions in depression and other brain disorders

T Prévot, E Sibille - Molecular psychiatry, 2021 - nature.com
Cognitive dysfunctions, including impaired attention, learning, memory, planning and
problem solving, occur in depressive episodes, often persist during remission, predict …

Targeting glutamate signalling in depression: progress and prospects

JW Murrough, CG Abdallah, SJ Mathew - Nature Reviews Drug …, 2017 - nature.com
Major depressive disorder (MDD) is severely disabling, and current treatments have limited
efficacy. The glutamate N-methyl-d-aspartate receptor (NMDAR) antagonist ketamine was …

Glutamate and gamma-aminobutyric acid systems in the pathophysiology of major depression and antidepressant response to ketamine

MS Lener, MJ Niciu, ED Ballard, M Park, LT Park… - Biological …, 2017 - Elsevier
In patients with major depressive disorder or bipolar disorder, abnormalities in excitatory
and/or inhibitory neurotransmission and neuronal plasticity may lead to aberrant functional …

[HTML][HTML] Glutamate and GABA homeostasis and neurometabolism in major depressive disorder

A Sarawagi, ND Soni, AB Patel - Frontiers in psychiatry, 2021 - frontiersin.org
Major depressive disorder (MDD) is a leading cause of distress, disability, and suicides. As
per the latest WHO report, MDD affects more than 260 million people worldwide. Despite …

Prevalencia, causas y tratamiento de la depresión Mayor

EA Pérez-Padilla, VM Cervantes-Ramírez… - Revista …, 2017 - scielo.org.mx
La depresión mayor representa un problema de salud pública debido a su alta prevalencia.
La etiología de la depresión es compleja ya que en ella intervienen factores psicosociales …